MDS subclassification-do we still have to count blasts?
Leukemia
.
2023 Apr;37(4):942-945.
doi: 10.1038/s41375-023-01855-7.
Epub 2023 Feb 22.
Authors
Sandra Huber
1
,
Torsten Haferlach
1
,
Heiko Müller
1
,
Manja Meggendorfer
1
,
Stephan Hutter
1
,
Gregor Hoermann
1
,
Constance Baer
1
,
Wolfgang Kern
1
,
Claudia Haferlach
2
Affiliations
1
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
2
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany. claudia.haferlach@mll.com.
PMID:
36813994
PMCID:
PMC10079547
DOI:
10.1038/s41375-023-01855-7
No abstract available
MeSH terms
Bone Marrow*
Humans
Myelodysplastic Syndromes*
Prognosis